AI health startup Cloudphysician, a full-stack tech and operations company that partners with hospitals to manage patients in their ICU and emergency departments, announced the appointment of Dr. Mandar Vaidya as CEO-India, effective June 2024.
Previously, Mandar was a former partner at McKinsey & Co., where he led healthcare practices in Asia and developed strategies for hospitals and pharmaceutical companies.
AI health startup Cloudphysician, a full-stack tech and operations company that partners with hospitals to manage patients in their ICU and emergency departments, announced the appointment of Dr. Mandar Vaidya as CEO-India, effective June 2024.
Previously, Mandar was a former partner at McKinsey & Co., where he led healthcare practices in Asia and developed strategies for hospitals and pharmaceutical companies. Mandar was regional CEO at OYO for four years, where he led multiple geographies outside of India (Europe, Southeast Asia, the Middle East, and Japan). Additionally, Mandar is an independent director on the board of Cipla Limited.
Dr. Dhruv Joshi and Dr. Dileep Raman, co-founders at Cloudphysician, said, “With Mandar joining our team, we are entering an exciting new phase in our growth journey. The healthcare landscape in India is evolving, and there is a significant opportunity for tech-enabled solutions to establish sustainable models of care delivery. His industry expertise, insights, and laser-like execution focus will help drive our mission forward, enabling us to reach more patients and hospitals.”
Cloudphysician has empowered partner hospitals to see up to a 40% reduction in their ICU mortality rates with 24/7 AI-enabled clinical support, as per a company statement.
Cloudphysician recently raised $10.5 million in a Series A funding round led by Peak XV Partners, with participation from Elevar Equity and venture debt firm Panthera Peak. Mandar aims to unlock opportunities to ensure that high-quality intensive care is accessible, scalable, and cost-effective for hospitals everywhere.
The company says that it will use the funding to increase its presence in India and international markets. It will also be used to make its own artificial intelligence platform. Speaking to the Economic Times, Joshi said, “We want to further build our AI platform, Radar, and enhance its capabilities as a co-pilot for care for doctors and nurses.”